This inventor holds 1 USPTO granted patent. Top assignee: Yunnan Institute of Materia Medica. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Yunlin Wei
Introduction
Yunlin Wei is a notable inventor based in Kunming, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of new pharmaceutical compounds. His work focuses on innovative solutions for mood disorders and related conditions.
Latest Patents
Yunlin Wei holds a patent for a polymorph of triaryldimethylpiperazine dihydrochloride. The patent, titled "Polymorph of triaryldimethylpiperazine dihydrochloride and preparation method and application thereof," discloses five polymorph forms B, P, F, J, and O. These forms are associated with a compound that has potential applications in the manufacture of a medicament for preventing or treating mood disorders or diseases related to the δ opioid receptor. He has 1 patent to his name.
Career Highlights
Wei is affiliated with the Yunnan Institute of Materia Medica, where he conducts research and development in medicinal compounds. His work has been instrumental in advancing the understanding of pharmaceutical applications in mental health.
Collaborations
Yunlin Wei collaborates with several esteemed colleagues, including Jingkun Wang and Zhaoyun Zhu. Their combined expertise enhances the research output and innovation at the Yunnan Institute of Materia Medica.
Conclusion
Yunlin Wei's contributions to medicinal chemistry and his innovative patent work highlight his role as a key figure in the development of new treatments for mood disorders. His ongoing research promises to impact the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile